ENTLEP001

N/A

Report date: 2024/09/02 11:12:48

Base Information

Drug NameENTLEP001
Drug Alias NameObesity/Congenital Generalized Lipodystrophy (Entos Pharmaceuticals)ENTLEP001ENTLEP-001
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsObesityMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEntos Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEntos Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A